8/4/16
Phase 1 clinical trials have begun on the The NIAID Zika virus investigational DNA vaccine at three locations in the United States. Prevention of Zika virus infection is a public health imperative due to the devastating sequelae to the fetus if acquired during pregnancy. Although still early in it’s development, this is an exciting next step in bringing a Zika Vaccine to the public. NIH News Release: Zika vaccine human trials